Literature DB >> 25550924

Clinical in vestigation of misdiagnosis of invasive pulmonary aspergillosis in 26 immunocompetent patients.

Rong-Rong Zhang1, Su-Fang Wang1, Huai-Wei Lu2, Zhi-Hua Wang3, Xiao-Ling Xu4.   

Abstract

The clinical features of invasive pulmonary aspergillosis (IPA) in immunocompromised patients is well studied in the past decades. While the manifestations of IPA in immunocompetent patients remain unclear.The purpose of this study was to determine the clinical and radiological manifestations of invasive pulmonary aspergillosis (IPA) in patients without immunosuppression, as well as the reasons for the misdiagnosis of IPA. We retrieved and retrospectively reviewed the records of 102 patients from whom surgical lung specimens of chronic inflammatory granulomas were harvested. 26 patients were eventually diagnosed with pulmonary aspergillosis on Grocott methenamine silver staining. We investigated these patients in detail. We found that the rate of misdiagnosis before the lung surgery was as high as 73%. The most common symptom was hemoptysis, and the main feature in radiology was nodule or mass lesion. Air crescent sign or Halo sign were not common in our study. The atypical radiological manifestations and non-specific clinical findings make the diagnosis of IPA difficult and lead to a high misdiagnosis rate.

Entities:  

Keywords:  Invasive pulmonary aspergillosis; clinical characteristics; immunocompetent; radiological features

Year:  2014        PMID: 25550924      PMCID: PMC4276182     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

1.  Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL.

Authors:  Issam Raad; Hend Hanna; Armando Huaringa; David Sumoza; Ray Hachem; Maher Albitar
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

2.  Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases.

Authors:  J Qin; Y Fang; Y Dong; K Zhu; B Wu; Y An; H Shan
Journal:  Br J Radiol       Date:  2012-04-11       Impact factor: 3.039

3.  [A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007].

Authors:  You-Ning Liu; Dan-Yang She; Tie-Ying Sun; Zhao-Hui Tong; Bei He; Yi Xiao; Li-Xian He; Jie-Ming Qu; Xiao-Qing Liu; Er-Ran Li; Ping Chen; Zhong-Sen Ma; Yi Shi; Yu-Lin Feng; Shu-Juan Jiang; Sheng-Dao Xiong; Cheng-Ping Hu
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2011-02

4.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

5.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 6.  Aspergillosis in the 'nonimmunocompromised' host.

Authors:  David A Stevens; George L Melikian
Journal:  Immunol Invest       Date:  2011       Impact factor: 3.657

Review 7.  Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients.

Authors:  F Reichenberger; J M Habicht; A Gratwohl; M Tamm
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

Review 8.  Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings.

Authors:  T Franquet; N L Müller; A Giménez; P Guembe; J de La Torre; S Bagué
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

9.  Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.

Authors:  J Jewkes; P H Kay; M Paneth; K M Citron
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.